Abstract
Although there is a large body of information available on the subject of adverse drug reactions, much of it is based on anecdotal case reports or uncontrolled studies of drug recipients. These studies often come to unwarranted conclusions or at least to conclusions which are difficult to interpret fully, resulting in considerable differences of opinion even amongst acknowledged experts (Koch-Weser et al. 1977). In an attempt to circumvent some of the ambiguities inherent in many of the reports of adverse drug effects Feinstein and his colleagues have proposed using a stepwise decision process for their operational assessment (Kramer et al. 1979; Hutchinson et al. 1979; Leventhal et al. 1979). Unfortunately such developments have little bearing on the present report since it is not possible using this technique to assess retrospectively the validity of most published studies of adverse reactions. Nevertheless it is to be hoped that approaches such as advocated by this group will be adopted in the future, so as to render interpretation of case reports of adverse reactions a much easier task.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andrejak M (1976) Colite aigue iatrogene au sulphamethoxazole-trimethoprim. Nouv Presse Med 5: 1998–1999
Ansdell VE, Wright SG, Hutchinson DBA (1976) Megaloblastic anaemia associated with combined pyrimethamine and cotrimoxazole administration. Lancet 2: 1257
Appel GB, Neu HC (1977) The nephrotoxicity of antimicrobial agents. N Engl J Med 296: 784–787
Arndt KA, Jick H (1976) Rates of cutaneous reactions to drugs. JAMA 235: 918–923
Barnett DP, Hancock BW (1975) Anticoagulant resistance: an unusual case. Br Med J I: 608–609
Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB (1978) Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. New Engl J Med 298: 531–534
Bennett WM, Raven R (1976) Urinary tract infections with severe renal diseases. JAMA 236: 946–948
Berglund F, Killander J, Pompeius R (1975) The effect of trimethoprim-sulphamethoxazole on the renal excretion of creatinine in man. J Urol 114: 802–808
Bergoend H, Loffler A, Amar R, Maleville J (1968) Reactions cutanees survenues au cours de la prophylaxie de masse de la meningite cerebro-spinale par un sulfamide long-retard (A propos de 997 cas). Ann Dermatol Syphiligr 95: 481–490
Böttiger LE, Westerholm B (1972) Thrombocytopenia: II. Drug-induced thrombocytopenia. Acta Med Scand 191: 541–548
Böttiger LE, Furhoff AK, Holmberg L (1979a) Fatal reactions to drugs. Acta Med Scand 205: 451–456
Böttiger LE, Furhoff AK, Holmberg L (1979b) Drug induced blood dyscrasias. Acta Med Scand 205: 457–461
Border WA, Lehman DH, Egan JD, Sass HJ, Glode JE, Wilson CB (1974) Renal failure and interstitial nephritis. N Engl J Med 291: 381–384
Buchanan N (1978) Sulphamethoxazole, hypoalbuminaemia, crystalluria and renal failure. Br Med J 2: 172
Bull GM, Joekes AM, Lowe KG (1958) Acute renal failure due to poisons and drugs. Lancet 1: 134–136
Cameron A, Thomas M (1977) Pseudomembranous colitis and co-trimoxazole. Br Med J 1: 1321
Chanarin T, England JM (1972) Toxicity of trimethoprim-sulphamethoxazole in patients with megaloblastic hemopoiesis. Br Med J 1: 651–653
Cohen HN, McIntyre H, Beastall GH, Ratcliffe W, Kennedy JS, Thomson JA (1979) The antithyroid effects of trimethoprim/sulphonamide preparations in man and rodents. Scott Med J 24: 255
DeGruchy GC (1975) Drug-induced blood disorders. Blackwell Scientific, Oxford Dickson HG (1978) Trimethoprim-sulphamethoxazole and thrombocytopenia. Med J Aust 2: 5–7
Drugs and Therapeutics Bulletin (1979) Co-trimoxazole — too toxic for minor infections? Drug Ther Bull 17: 66–68
Editorial (1981) Antibiotic-associated colitis — the continuing saga. Br Med J 282: 1913–1914
Felix RH, Ive FA (1974) Skin reactions to practolol. Br Med J 2: 333
Frisch JM (1973a) Clinical experience with adverse reactions to trimethoprim-sulphamethoxazole. J Infect Dis [Suppl] 128: 5607 - S611
Frisch JM ( 1973 b) Trimethoprim/sulphamethoxazole in bacterial infections. In: Bernstein LS, Salter AJ (eds) Churchill Livingstone, London, pp 227–234
Girdwood RH (1973) Trimethoprim/sulphamethoxazole: long-term therapy and folate levels. Med J Aust [Suppl] 1: 34–36
Girdwood RH (1974) Death after taking medicaments. Br Med J 1: 501–504
Girdwood RH (1976) The nature of possible adverse reactions to co-trimoxazole. Scand J Infect Dis [Suppl] 8: 10–17
Hall CL (1974) Co-trimoxazole and azathioprine: a safe combination. Br Med J 4: 15–16
Halpern GM (1972) Unusual reaction to trimethoprim in combined therapy. Br Med J 1: 691
Hassall C, Feetham CL, Leach RH, Meynell MJ (1974) Potentiation of warfarin by cotrimoxazole. Br Med J 2: 684
Hjortshoj A, Elsborg L, Jensen E (1978) Folate status during long-term therapy with trimethoprim and sulphadiazine. Chemotherapy 24: 327–331
Horn B, Cottier P (1974) Serum creatinine concentration before and during treatment with co-trimoxazole. Schweiz Med Wochenschr 104: 1809–1812
Hulme B, Reeves DS (1971) Leucopenia associated with trimethoprim-sulphamethoxazole after renal transplantation. Br Med J 3: 610–612
Hurwitz N, Wade OL (1969) Intensive hospital monitoring of adverse reactions to drugs. Br Med J 1: 531–536
Hutchinson TA, Leventhal JM, Kramer MS, Karch FE, Lipman AB, Feinstein AR (1979) An algorithm for the assessment of adverse drug reactions: II. Demonstration of reproducibility and validity. J Am Med Assoc 242: 633
Inman WHW (1977) Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone. Br Med J 1: 1500–1505
Jick H (1977) The discovery of drug-induced illness. N Engl J Med 296: 481–485
Kahn SB, Fein SA, Brodsky I (1968) Effect of trimethoprim on folate metabolism in man. Clin Pharmacol Ther 9: 550–560
Kalowski S, Nanra RS, Matthew TH, Kincaid-Smith P (1973) Deterioration in renal function in association with co-trimoxazole therapy. Lancet 1: 394–397
Kasanen A, Antilla M, Elfving R et al. (1978) Trimethoprim. Ann Clin Res [Suppl 22] 10: 539
Koch-Weser J, Sidel VW, Dexter H, Parish C, Finer DC, Kanarek P (1971) Adverse reactions to sulfisoxazole, sulfamethoxazole, and nitrofurantoin. Arch Intern Med 128: 399–404
Koch-Weser J, Sellers EM, Zacest R (1977) The ambiguity of adverse drug reactions. Eur J Clin Pharmacol 11: 75–78
Kramer MS, Leventhal JM, Hutchinson TA, Feinstein AR (1979) An algorithm for the operational assessment of adverse drug reactions. JAMA 242: 623–632
Lawson DH (1979) Detecting adverse drug reactions. Br J Clin Pharmacol 7: 13–18
Lawson DH, Henry DA (1977) Fatal agranulocytosis attributed to co-trimoxazole therapy. Br Med J 2: 316
Lawson DH, Jick H (1978) Adverse reactions to co-trimoxazole in hospitalised medical patients. Am J Med Sci 275: 53–57
Lawson DH, MacDonald S (1977) Antibiotic therapy in medical wards. Postgrad Med J 53: 306–309
Leventhal JM, Hutchison TA, Kramer MS, Feinstein AR (1979) An algorithim for the operational assessment of adverse drug reactions. III. Results of tests among clinicians. JAMA 242: 1991–1994
Lyell A (1979) Toxic epidermal necrolysis (the scalded skin syndrome) a reappraisal. Br J Dermatol 100: 69–86
McQueen EG (1974) New Zealand committee on adverse drug reactions: ninth annual report. NZ Med J 80: 305–311
McQueen EG (1975) New Zealand committee on adverse drug reactions: tenth annual report. NZ Med J 82: 308–309
McQueen EG (1976) New Zealand committee on adverse drug reactions: eleventh annual report. NZ Med J 84: 450–453
McQueen EG (1977) New Zealand committee on adverse drug reactions: twelfth annual report. NZ Med J 86: 248–250
McQueen EG (1978) New Zealand committee on adverse drug reactions: thirteenth annual report. NZ Med J 89: 145–149
Mihic M, Mautner LS, Feness JZ, Grant K (1975) Effect of trimethoprim sulphamethoxazole on blood insulin and glucose concentrations in diabetics. Can Med Assoc J 112:S 80-S 82
Ministry of Health and Welfare (1979) Adverse reactions of sulphamethoxazole-trimethoprim compounds. Nihon Iji Shinpo (Jpn Med J) 242: 1991–1994
Odell GB, Cohen SN, Kelly PC (1969) Studies in kernicterus. J Pediatr 74: 214–217
O’Reilly RA (1974) Studies of the optical enantiomorphs of warfarin in man. Clin Pharmacol Ther 16: 348–354
O’Reilly RA (1980) Stereoselective interaction of trimethoprim-sulfamethoxazole with the separated enantiomorphs of racemic warfarin in man. New Engl J Med 302: 33–35
Reid DWJ (1975) Maternal and transplacental kinetics of trimethoprim and sulphamethoxazole. Can Med Assoc J [Suppl] 112:67 S
Richmond JM, Whitworth JA, Fairley KF, Kincaid-Smith P (1979) Co-trimoxazole nephrotoxicity. Lancet 1: 493
Roddis MJ (1978) Antibiotic associated colitis: a retrospective study of fifteen cases. Age Ageing 7: 182–188
Salter AJ (1973) The toxicity profile of trimethoprim/sulphamethoxazole after four years of independent use. Med J Aust [Suppl] 1: 70–74
Shapiro S, Slone D, Siskind V, Lewis GP, Kick H (1969) Drug rash with ampicillin and other penicillins. Lancet 2: 969–972
Siegel WH (1977) Unusual complications of therapy with sulphamethoxazole-trimethoprim. J Urol 117: 397
Smithells RW (1978) Drugs, infections, and congenital abnormalities. Arch Dis Child 53: 93–99
Tasker PRW, MacGregor GA, de Wardener HE, Thomas RD, Jones NF (1975) Use of cotrimoxazole in renal failure. Lancet 1: 1216–1218
Thiersch JB (1952) Therapeutic abortions with a folic acid antagonist 4-aminopteroylglutamic acid (4-amino PGA) administered by the oral route. Am J Obstet Gynecol 63: 1298–1304
Tilstone WJ, Gray JMB, Nimmo-Smith RH, Lawson DH (1977) Interaction between warfarin and sulphamethoxazole. Postgrad Med J 53: 388–390
Williams JD (1969) The treatment of bacteruria in pregnant women with sulphamethoxazole and trimethoprim. Postgrad Med J [Suppl 711: 45
Winterborn MH, Mann JR (1973) Anuria due to sulphadiazine. Arch Dis Child 48: 915–917
Wooley JL, Ragouzeous A, Brent DA, Sigel CW (1980) Sulfonamide crystalluria: Isolation and identification of sulfamethoxazole and four metabolites in urinary calculi. Curr Chemother Inf Dis 552–554
Wormser GP, Keusch GT (1979) Trimethoprim-sulphamethoxazole in the United States. Ann Intern Med 91: 420–429
Ziel HK, Finkle WD (1975) Increased risk of endometrial carcinoma amongst users of conjugated oestrogens. N Engl J Med 293: 1167–1170
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lawson, D.H. (1983). Adverse Effects of Co-trimoxazole. In: Hitchings, G.H. (eds) Inhibition of Folate Metabolism in Chemotherapy. Handbook of Experimental Pharmacology, vol 64. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81890-5_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-81890-5_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81892-9
Online ISBN: 978-3-642-81890-5
eBook Packages: Springer Book Archive